uniQure N.V (NASDAQ: QURE)’s stock price has soared by 3.68 in relation to previous closing price of 13.86. Nevertheless, the company has seen a loss of -0.14% in its stock price over the last five trading days. zacks.com reported 2025-04-21 that uniQure (QURE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Is It Worth Investing in uniQure N.V (NASDAQ: QURE) Right Now?
The 36-month beta value for QURE is also noteworthy at 0.11. There are mixed opinions on the stock, with 9 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for QURE is 50.09M, and at present, short sellers hold a 10.50% of that float. The average trading volume of QURE on April 30, 2025 was 1.39M shares.
QURE’s Market Performance
QURE’s stock has seen a -0.14% decrease for the week, with a 35.57% rise in the past month and a -5.71% fall in the past quarter. The volatility ratio for the week is 5.53%, and the volatility levels for the past 30 days are at 10.57% for uniQure N.V The simple moving average for the last 20 days is 26.60% for QURE’s stock, with a simple moving average of 44.20% for the last 200 days.
Analysts’ Opinion of QURE
Many brokerage firms have already submitted their reports for QURE stocks, with Chardan Capital Markets repeating the rating for QURE by listing it as a “Buy.” The predicted price for QURE in the upcoming period, according to Chardan Capital Markets is $38 based on the research report published on April 01, 2025 of the current year 2025.
Raymond James gave a rating of “Outperform” to QURE, setting the target price at $20 in the report published on October 10th of the previous year.
QURE Trading at 18.07% from the 50-Day Moving Average
After a stumble in the market that brought QURE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.08% of loss for the given period.
Volatility was left at 10.57%, however, over the last 30 days, the volatility rate increased by 5.53%, as shares surge +45.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.45% upper at present.
During the last 5 trading sessions, QURE fell by -0.14%, which changed the moving average for the period of 200-days by +64.79% in comparison to the 20-day moving average, which settled at $11.35. In addition, uniQure N.V saw -18.63% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QURE starting from Kapusta Matthew C, who sale 28,341 shares at the price of $10.29 back on Mar 04 ’25. After this action, Kapusta Matthew C now owns 651,454 shares of uniQure N.V, valued at $291,629 using the latest closing price.
Abi-Saab Walid, the Chief Medical Officer of uniQure N.V, sale 1,350 shares at $10.29 during a trade that took place back on Mar 04 ’25, which means that Abi-Saab Walid is holding 151,903 shares at $13,891 based on the most recent closing price.
Stock Fundamentals for QURE
Current profitability levels for the company are sitting at:
- -6.96 for the present operating margin
- 0.13 for the gross margin
The net margin for uniQure N.V stands at -8.83. The total capital return value is set at -0.37. Equity return is now at value -238.46, with -34.51 for asset returns.
Based on uniQure N.V (QURE), the company’s capital structure generated 1.11 points at debt to capital in total, while cash flow to debt ratio is standing at -2.76. The debt to equity ratio resting at -9.78. The interest coverage ratio of the stock is -2.96.
Currently, EBITDA for the company is -160.75 million with net debt to EBITDA at 0.58. When we switch over and look at the enterprise to sales, we see a ratio of 25.61. The receivables turnover for the company is 4.61for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.74.
Conclusion
In summary, uniQure N.V (QURE) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
